# Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)

> **NCT00092833** · PHASE3 · TERMINATED · sponsor: **Organon and Co** · enrollment: 49 (actual)

## Conditions studied

- Hypercholesterolemia, Familial
- Lipid Metabolism, Inborn Errors

## Interventions

- **DRUG:** Comparator: ezetimibe

## Key facts

- **NCT ID:** NCT00092833
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-07
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092833, "Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00092833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*